Related Experiment Video
Updated: Dec 30, 2025

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
DLEU1: A Functional Long Noncoding RNA in Tumorigenesis
Chaoying Song1,2, Jiali Zhang1,2, Zongyao Zhao1,2
1China Three Gorges University, School of Medicine, Yichang, 443002, Hubei, China.
Background:
LncRNA DLEU1 participates in various biological processes, playing an indispensable role in the pathophysiology of human diseases, especially in tumorigenesis and other processes. Besides, it may represent a promising target for biotherapy in numerous tumors. The aim of this review was to reveal the pathophysiological functions and mechanisms of lncRNA DLEU1 in different types of cancer.
Methods:
In this review, current studies concerning the biological functions and mechanisms of DLEU1 in tumor development are summarized and analyzed; the related researches are collected through a systematic retrieval of PubMed.
Results:
DLEU1 is a novel cancer-associated lncRNA that has been proved to be abnormally elevated in various malignancies, containing osteosarcoma, glioma, glioblastoma multiforme, hepatocellular carcinoma, bladder cancer, cervical cancer, non-small cell lung cancer, pancreatic ductal adenocarcinoma, colorectal cancer, oral squamous cell carcinoma, endometrial cancer, gastric cancer, Burkitt lymphoma and ovarian carcinoma. Besides, lncRNA LDEU1 has been demonstrated involving in the procession of proliferation, migration, invasion and inhibition of apoptosis of cancer cells.
Conclusion:
Long non-coding RNA DLEU1 is likely to represent an available biomarker or a potential therapeutic target in multiple tumors.
Insights
Long non-coding RNA DLEU1 (lncRNA DLEU1) is elevated in many cancers and drives tumor growth. This lncRNA shows promise as a diagnostic biomarker and therapeutic target for various malignancies.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Long non-coding RNAs (lncRNAs) play critical roles in biological processes.
- lncRNA DLEU1 is implicated in the pathophysiology of human diseases, particularly in cancer development.
- DLEU1 may serve as a potential target for cancer biotherapy.
Purpose of the Study:
- To review and analyze the pathophysiological functions and mechanisms of lncRNA DLEU1 in various cancer types.
- To consolidate current research on DLEU1's role in tumor development.
Main Methods:
- Systematic literature retrieval from PubMed.
- Summary and analysis of existing studies on DLEU1's biological functions and mechanisms in tumors.
Main Results:
- DLEU1 is frequently overexpressed in numerous cancers, including osteosarcoma, glioma, and hepatocellular carcinoma.
- lncRNA DLEU1 is involved in promoting cancer cell proliferation, migration, and invasion.
- DLEU1 also plays a role in inhibiting apoptosis in cancer cells.
Conclusions:
- lncRNA DLEU1 is a significant cancer-associated lncRNA.
- DLEU1 is a potential biomarker for early cancer detection.
- DLEU1 represents a promising therapeutic target for multiple tumor types.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
Non-LTR Retrotransposons
MicroRNAs
MicroRNAs
Types of RNA
RNA Performs Diverse...
